Endovia Health Sciences, Inc.
EDVA- Exchange
- NYSE
- Industry
- Beverages
- SEC CIK
- 0001553788
No open-market purchases or sales by Endovia Health Sciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $172.1K in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Endovia Health Sciences, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- −3 vs. Q3 2025
- Shares held
- 217.5K
- +109.1K (+100.7%) vs. Q3 2025
- Total value
- $150.7K
- −$105.0K (−41.0%) vs. Q3 2025
- New holders
- 3
- 5 more added
- Sold out
- 6
- 2 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EDVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $172.1K |
| Q1 2026 | 16 | $243.9K |
| Q4 2025 | 14 | $150.7K |
| Q3 2025 | 17 | $255.7K |
| Q2 2025 | 12 | $260.9K |
| Q1 2025 | 11 | $93.4K |
| Q4 2024 | 34 | $720.8K |
| Q3 2024 | 31 | $1.04M |
| Q2 2024 | 32 | $903.3K |
| Q1 2024 | 28 | $1.37M |
| Q4 2023 | 30 | $1.40M |
| Q3 2023 | 28 | $1.61M |
| Q2 2023 | 26 | $2.93M |
| Q1 2023 | 21 | $3.45M |
| Q4 2022 | 24 | $2.19M |
| Q3 2022 | 23 | $2.83M |
| Q2 2022 | 22 | $6.81M |
| Q1 2022 | 25 | $7.96M |
| Q4 2021 | 15 | $484.0K |
| Q3 2021 | 13 | $919.0K |
| Q2 2021 | 9 | $1.01M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Endovia Health Sciences, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lifetime Wealth Management P.C. | 66,050 | $45.6K | 0.03% | +66,050 | New |
| RSM US Wealth Management LLC | 34,173 | $24.9K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 26,552 | $18.3K | 0.00% | +14,126+113.7% | Added |
| HRT Financial LP | 24,288 | $16.0K | 0.00% | +11,103+84.2% | Added |
| Two Sigma Securities, LLC | 22,119 | $15.3K | 0.00% | +22,119 | New |
| UBS Group AG | 15,095 | $10.4K | 0.00% | +15,085+150,850.0% | Added |
| Geode Capital Management, LLC | 13,928 | $9.62K | 0.00% | +13,928 | New |
| Vanguard Group Inc | 11,086 | $7.65K | 0.00% | −4,981−31.0% | Reduced |
| Tower Research Capital LLC (TRC) | 4,021 | $2.78K | 0.00% | +1,607+66.6% | Added |
| SBI Securities Co., Ltd. | 72 | $50 | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 53 | $37 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 19 | $13 | 0.00% | +1+5.6% | Added |
| Delos Wealth Advisors, LLC | 16 | $12 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1 | $1 | 0.00% | −14−93.3% | Reduced |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −13,785−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −12,300−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −3,795−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |